|
Volumn 105, Issue 3, 2001, Pages 151-155
|
Filgrastim (r-metHuG-CSF) in the 21st century: SD/01
|
Author keywords
Chemotherapy; Clinical studies; Filgrastim; Lung cancer; Myelosuppression; Neutropenia; Normal volunteer; Pegylated molecule; Preclinical studies
|
Indexed keywords
CARBOPLATIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ARTICLE;
BONE PAIN;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG CLEARANCE;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG SCREENING;
HEADACHE;
HUMAN;
LUNG NON SMALL CELL CANCER;
NONHUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RAT;
THROMBOCYTOPENIA;
TREATMENT INDICATION;
ANIMALS;
FILGRASTIM;
GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HEMATOPOIETIC STEM CELL MOBILIZATION;
HUMANS;
NEUTROPENIA;
RECOMBINANT PROTEINS;
|
EID: 0034913652
PISSN: 00015792
EISSN: None
Source Type: Journal
DOI: 10.1159/000046557 Document Type: Article |
Times cited : (40)
|
References (10)
|